Finance

Lists
CHE:NYSE
Chemed Corp
USD 499,82
+0,32%
(+1,57) 1D
USD 499,82
0,00% (0,00)
After hours
Closed: 9 Okt., 16:00:04 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CHE...
Open
USD 497,65
High
USD 502,15
Low
USD 493,43
Mkt. cap
6,53 mjd
Avg. vol.
157,62 k
Volume
134,46 k
Dividend
0,56%
Quarterly dividend
USD 0,70
Ex-dividend date
17 Aug. 2026
P/E ratio
25,09
52-wk high
USD 557,00
52-wk low
USD 365,20
EPS
USD 19,92
Beta
0,51
Shares outstanding
13,07 m
No. of employees
16 k
Open
USD 497,65
High
USD 502,15
Low
USD 493,43
Mkt. cap
6,53 mjd
Avg. vol.
157,62 k
Volume
134,46 k
Dividend
0,56%
Quarterly dividend
USD 0,70
Ex-dividend date
17 Aug. 2026
P/E ratio
25,09
52-wk high
USD 557,00
52-wk low
USD 365,20
EPS
USD 19,92
Beta
0,51
Shares outstanding
13,07 m
No. of employees
16 k
News stories
From web sources and news partners
About Chemed Corp
CEOKevin J Mcnamara
Employees15,8 k
Founded1970
HeadquartersCincinnati, Ohio, Verenigde State van Amerika
SectorHealth care provider
Websitechemed.com
Analyst ratings
Based on 4 analysts giving stock ratings to CHE in the past 3 months
Buy
Buy
2
Hold
2
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CHE in the last 3 months.
Highest
Current USD 499,82
USD 650,00 (+30,05%)
Average
USD 584,50 (+16,94%)
Lowest
USD 548,00 (+9,64%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joanna Gajuk
Bank of America Securities
Hold
Maintained
USD 550,00
+10%
10/08/2026
A.J. Rice
UBS
Buy
Initiated
USD 650,00
+30%
09/25/2026
Michael Wiederhorn
Oppenheimer
Buy
Reiterated
USD 590,00
+18%
07/31/2026
Ben Hendrix
RBC Capital
Hold
Maintained
USD 548,00
+9,6%
07/30/2026
Brian Tanquilut
Jefferies
Hold
Maintained
USD 400,00
-20%
02/26/2026
Last report
29 Jul. 2026
Fiscal period
Q2 2026
USD 6,06 / USD 5,60
+8,21%beat
Revenue / Est. (USD)
673,25 m / 665,04 m
+1,24%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
624,90 m
639,34 m
657,51 m
673,25 m
Cost of goods sold
427,99 m
414,17 m
441,75 m
451,78 m
Cost of revenue
427,99 m
414,17 m
441,75 m
451,78 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
105,78 m
102,80 m
114,32 m
115,20 m
Operating expense
122,16 m
118,91 m
131,19 m
132,27 m
Total operating expenses
550,15 m
533,07 m
572,94 m
584,05 m
Operating income
74,75 m
106,26 m
84,58 m
89,20 m
Other non operating income
6,70 m
3,75 m
3,88 m
3,70 m
EBT including unusual items
83,54 m
105,44 m
88,84 m
91,33 m
EBT excluding unusual items
83,54 m
111,05 m
88,84 m
91,33 m
Income tax expense
19,31 m
28,69 m
22,54 m
23,63 m
Effective tax rate
23,11%
27,21%
25,37%
25,87%
Other operating expenses
148,00 k
-225,00 k
-8,00 k
78,00 k
Net income
64,24 m
76,75 m
66,30 m
67,70 m
Net profit margin
10,28%
12,00%
10,08%
10,06%
Earnings per share
5,27
6,42
5,65
6,06
Interest and investment income
2,56 m
1,56 m
890,00 k
214,00 k
Interest expense
-457,00 k
-521,00 k
-512,00 k
-1,79 m
Net interest expenses
2,10 m
1,04 m
378,00 k
-1,58 m
Depreciation and amortization charges
13,66 m
13,76 m
14,30 m
14,27 m
EBITDA
90,98 m
118,29 m
101,45 m
106,19 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme